In the iconic "Sound of Music" score, "My Favorite Things," a young Julie Andrews lists snowflakes as objects that bring her ...

Division rocked the House on Tuesday as lawmakers from across the political divide picked holes in President William Ruto’s State of the Nation Address delivered on Thursday last week. While ...

There are plenty of distractions to deal with in our modern digital age—see if you can manage to get all the way through this article without turning your attention elsewhere at least once, for ...

Cato, N.Y. -- In September, when the ballots were printed for the town elections in Cato, it seemed the races were already won. There were no challengers for any of the five spots. That’s how things ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

Vertex Pharmaceuticals Incorporated remains a leader in cystic fibrosis treatments, fueling robust cash flow and funding a promising pipeline expansion. VRTX is seeing early but accelerating revenue ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Tesla’s new Standard Model 3 and Model Y are priced under $40K, but some of its competitors can steal their newfound thunder. In an announcement late on October 7, Tesla unveiled two new models ...

In this post, we will cover the best AI font generators that let you create custom, fancy fonts. While some of these tools allow you to turn your own handwriting into a digital font, others transform ...

On August 12, last month, on the lawns of Kakamega’s Masinde Muliro University, President William Ruto presided over the International Youth Day 2025 celebrations with the launch of Sinema Mashinani.

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.